SEC 13F Intelligence

Hayek Kallen Investment Management / NVS

Hayek Kallen Investment Management’s Novartis AG Position

Does Hayek Kallen Investment Management own Novartis AG (NVS)? Yes — 38.1K shares worth $6M (+1.89% of its 13F portfolio) as of Q1 2026, down from 38.9K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
38.1K
% of Portfolio
+1.89%
Quarters Held
28
currently held

Position History NVS

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $4MQ2 ’19: $4MQ3 ’19: $4MQ4 ’19: $4MQ4 ’19Q1 ’20: $4MQ3 ’20: $4MQ4 ’20: $4MQ1 ’21: $4MQ1 ’21Q2 ’21: $4MQ3 ’21: $4MQ4 ’21: $4MQ1 ’22: $4MQ1 ’22Q2 ’22: $3MQ3 ’22: $3MQ4 ’22: $4MQ1 ’23: $4MQ1 ’23Q2 ’23: $4MQ3 ’23: $4MQ4 ’23: $4MQ1 ’24: $4MQ1 ’24Q2 ’24: $4MQ3 ’24: $5MQ4 ’24: $4MQ1 ’25: $4MQ1 ’25Q2 ’25: $5MQ3 ’25: $5MQ1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202638.1K$6M+1.89%
Q3 202538.9K$5M+1.57%
Q2 202538.9K$5M+1.60%
Q1 202539.5K$4M+1.62%
Q4 202440.1K$4M+1.42%
Q3 202440.3K$5M+1.64%
Q2 202440.7K$4M+1.62%
Q1 202441.0K$4M+1.52%
Q4 202340.8K$4M+1.72%
Q3 202340.9K$4M+1.87%
Q2 202341.0K$4M+1.76%
Q1 202339.2K$4M+1.63%
Q4 202240.3K$4M+1.69%
Q3 202240.9K$3M+1.46%
Q2 202241.0K$3M+1.51%
Q1 202241.9K$4M+1.36%
Q4 202142.8K$4M+1.34%
Q3 202142.9K$4M+1.60%
Q2 202143.3K$4M+1.66%
Q1 202143.2K$4M+1.66%
Q4 202043.2K$4M+1.97%
Q3 202043.2K$4M+2.10%
Q1 202043.8K$4M+2.42%
Q4 201944.7K$4M+2.44%
Q3 201944.8K$4M+2.43%
Q2 201945.4K$4M+2.63%
Q1 201945.8K$4M+2.86%
Q4 201847.2K$4M+2.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hayek Kallen Investment Management’s full portfolio or all institutional holders of NVS.